Biotech Company to Invest $18.7 Million in New NC Lab and Create 242 Jobs
10/12/2011
Headquartered in San Diego, CA, Sequenom is committed to improving healthcare through revolutionary genetic analysis solutions. Its MaterniT21 test, expected to launch in the near future, screens for trisomy 21, the most common cause of Down Syndrome.
President Paul Maier said the North Carolina region shows great promise for Sequenom. He lauded its "ideal location" on the East Coast, as well as its "robust like-minded community and commitment to advancing our technologies through education and jobs creation."
"Sequenom is a cutting-edge company working on the forefront of biotechnological innovation," said Gov. Perdue. "They have selected North Carolina as the place to launch the latest advancement in testing for Down Syndrome because our history of strategic investment in education and job training guarantees they have the workforce they need to succeed."
The state's Economic Investment Committee voted to provide a Job Development Investment Grant to the firm. Sequenom is eligible to receive a grant equal to 60 percent of the state personal income withholding taxes derived from the creation of new jobs for each of the nine years in which the company meets annual performance targets.
If the company meets the targets called for under the agreement and sustains them for nine years, the grant could yield up to $2.3 million in maximum benefits.
Project Announcements
Canfor Expands Fulton, Alabama, Production Operations
04/22/2024
Tucker Door & Trim Plans Henrico County, Virginia, Operations
04/19/2024
Zekelman Industries Expands Blytheville, Arkansas, Operations
04/19/2024
Fibrebond Corporation Expands Webster Parish, Louisiana, Operations
04/19/2024
Master Steel Expands Hardeeville, South Carolina, Operations
04/19/2024
L3Harris Technologies Expands Orange County, Virginia, Operations
04/18/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024